Sub-header (14pt Franklin Gothic Demi)

First Page		Document Content
Date: 2015-03-01 21:43:46 Immune system Cytokines Antivirals Interferon beta-1a Pfizer Biogen Idec Interferon Pharmaceutical Benefits Scheme MS Australia Medicine Multiple sclerosis Pharmacology		Sub-header (14pt Franklin Gothic Demi) Add to Reading List Source URL: www.mssociety.org.au Download Document from Source Website File Size: 147,98 KB Share Document on Facebook

	Trustee Lynn Schenk Lynn Schenk is an attorney and consultant in private practice with extensive public policy and business experience. She serves on the Board of Directors for Sempra Energy, Biogen Idec, the Scripps Re DocID: 1tNv2 - View Document
	Tufts CSDD 2015 Leadership for Drug Development Teams Sponsor Rate Eligibility List: Amgen Inc. Bayer Healthcare Pharmaceuticals Biogen Idec, Inc. Biotechnology (BIO) DocID: 1eCyL - View Document
	Special Article Reprint • July 14, 2014 A CenterWatch Publication Biogen Idec turns to MyHealthTeam in successful test of social networks for enrolling MS clinical trial DocID: 1d2zh - View Document
	Tufts CSDD 2015 Postgraduate Course in Clinical Pharmacology, Drug Development, and Regulation Sponsor Rate Eligibility List: Amgen Inc. Bayer Healthcare Pharmaceuticals Biogen Idec, Inc. Biotechnology (BIO) DocID: 1cLP6 - View Document
	Bedrijf Abbvie Actelion Alcon ALK Abello Allergan DocID: 1aFBs - View Document